IN8BIO, INC. — Director's Dealing 2021

Aug 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2021-08-03

Reporting Person: Ho William Tai-Wei (Director, President, CEO and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-03	Common Stock	C	3070	—	Acquired	72999	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-03	Series A Preferred Stock	$	C	2792	Disposed		Common Stock (3070)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2289430	Direct
Common Stock	73000	Indirect
Common Stock	36500	Indirect
Common Stock	36500	Indirect
Common Stock	36500	Indirect

Footnotes

F1: Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into
Common Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the
closing of the Issuer's initial public offering.

F2: The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.